We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$270M
AUM Growth
+$25.1M
Cap. Flow
+$13.9M
Cap. Flow %
5.14%
Top 10 Hldgs %
32.64%
Holding
98
New
6
Increased
26
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$1.12M
2
ADI icon
Analog Devices
ADI
+$940K
3
SJM icon
J.M. Smucker
SJM
+$879K
4
FTV icon
Fortive
FTV
+$807K
5
CB icon
Chubb
CB
+$415K

Top Sells

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$789K
2
IONS icon
Ionis Pharmaceuticals
IONS
+$750K
3
IPGP icon
IPG Photonics
IPGP
+$583K
4
MON
Monsanto Co
MON
+$570K
5
MMM icon
3M
MMM
+$568K

Sector Composition

Rank Sector Weight
1 Healthcare 22.47%
2 Technology 19.8%
3 Industrials 16.64%
4 Consumer Staples 8.79%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$11.1M 4.09%
83,559
-1,180
-1% -$151K
MMM icon
2
3M
MMM
$83.4B
$9.99M 3.7%
57,409
-3,399
-6% -$568K
PG icon
3
Procter & Gamble
PG
$349B
$9.66M 3.58%
110,864
-2,855
-3% -$252K
CNI icon
4
Canadian National Railway
CNI
$78.3B
$9.08M 3.36%
112,066
+868
+0.8% +$66.2K
ATR icon
5
AptarGroup
ATR
$8.46B
$8.39M 3.1%
96,566
+473
+0.5% +$38.9K
ADP icon
6
Automatic Data Processing
ADP
$102B
$8.22M 3.04%
80,259
+1,835
+2% +$186K
AAPL icon
7
Apple
AAPL
$4.9T
$8.1M 3%
224,900
-2,700
-1% -$99.8K
NVS icon
8
Novartis
NVS
$293B
$7.73M 2.86%
103,285
+2,132
+2% +$151K
XOM icon
9
ExxonMobil
XOM
$611B
$7.53M 2.79%
93,294
+3,175
+4% +$260K
MA icon
10
Mastercard
MA
$480B
$7.31M 2.7%
60,192
-77
-0.1% -$9.13K
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.23T
$7.15M 2.65%
153,900
+3,100
+2% +$145K
FISV
12
Fiserv Inc
FISV
$27B
$6.73M 2.49%
110,002
-564
-0.5% -$34.1K
CVS icon
13
CVS Health
CVS
$137B
$6.72M 2.49%
83,522
-640
-0.8% -$50.5K
HD icon
14
Home Depot
HD
$338B
$6.69M 2.48%
43,630
-660
-1% -$101K
CB icon
15
Chubb
CB
$137B
$6.68M 2.47%
45,946
+2,951
+7% +$415K
ROK icon
16
Rockwell Automation
ROK
$51.4B
$6.41M 2.37%
39,610
+1,400
+4% +$221K
ABT icon
17
Abbott
ABT
$175B
$5.96M 2.2%
122,510
+2,920
+2% +$132K
INTC icon
18
Intel
INTC
$478B
$5.34M 1.98%
158,314
+1,945
+1% +$69.6K
RTX icon
19
RTX Corp
RTX
$261B
$5.29M 1.96%
68,840
+5,069
+8% +$380K
DHR icon
20
Danaher
DHR
$144B
$4.8M 1.77%
64,087
+5,411
+9% +$405K
XLNX
21
DELISTED
Xilinx Inc
XLNX
$4.38M 1.62%
68,045
+13
+0% +$820
ORCL icon
22
Oracle
ORCL
$364B
$4.32M 1.6%
86,131
-8,751
-9% -$399K
ADI icon
23
Analog Devices
ADI
$183B
$4.28M 1.58%
55,020
+11,829
+27% +$940K
PEP icon
24
PepsiCo
PEP
$187B
$3.99M 1.48%
34,525
-798
-2% -$91.5K
UL icon
25
Unilever
UL
$134B
$3.59M 1.33%
58,998
+4,758
+9% +$284K

Similar funds

Brian C. Broderick's Q2 2017 Portfolio in Review

As of Q2 2017, Brian C. Broderick held 98 positions worth $270M, up 10% from $245M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick deployed $13.9M of net new capital in Q2 2017, opening 6 new positions and adding to 26 existing holdings. Its largest new stake was EOG Resources: 12,150 shares worth $1.1M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was IPG Photonics, an estimated $583K trimmed.

  • Brian C. Broderick's largest Q2 2017 buy was EOG Resources: 12,150 shares worth $1.1M.
  • Brian C. Broderick added most to Analog Devices in Q2 2017, an estimated $940K increase.
  • Brian C. Broderick's biggest Q2 2017 reduction was IPG Photonics, cutting an estimated $583K.
  • Brian C. Broderick fully exited Enbridge in Q2 2017, selling an estimated $789K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $270M portfolio in Q2 2017.
  • Brian C. Broderick opened 6 new positions and closed 3 in Q2 2017.
  • Brian C. Broderick's portfolio value rose 10% quarter-over-quarter to $270M.

Based on Brian C. Broderick's 13F filing for Q2 2017, filed 21 Jul 2017.